Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
19.86
-0.81 (-3.92%)
Aug 21, 2026, 3:04 PM CST

SHE:002287 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
293.67376.44189.59403.43437.57666.63
Short-Term Investments
-91.56--224.65107.74
Trading Asset Securities
2,5552,5722,8071,9631,5391,184
Cash & Short-Term Investments
2,8493,0402,9972,3662,2021,958
Cash Growth
-12.65%1.43%26.64%7.49%12.42%6.98%
Accounts Receivable
641.83901.93942.91604.86825.39606.61
Other Receivables
5.673.226.1818.3410.03212.89
Receivables
647.5905.16949.09623.19835.42819.49
Inventory
328.71294.11185.33156.33127.77118.5
Prepaid Expenses
-0.120.091.116.881.99
Other Current Assets
137.868.9622.947.2520.8338.07
Total Current Assets
3,9634,3084,1543,1943,1922,936
Property, Plant & Equipment
1,7161,6961,6951,6471,144821.35
Long-Term Investments
509.18557.71561.241,0431,1161,357
Other Intangible Assets
290.11303.29325.5351.62374.81399.33
Long-Term Deferred Tax Assets
38.8340.4536.0239.3930.5926.68
Long-Term Deferred Charges
5.745.573.924.953.295.25
Other Long-Term Assets
206.514.7214.7917.6826.3321.28
Total Assets
6,7296,9166,7906,2985,8885,568

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
105.81204.74235.44266.2393.47184
Accrued Expenses
85.93346.74366.76352.86330.7297.27
Short-Term Debt
879.67915.55813.01451.52701.73501.81
Current Portion of Long-Term Debt
9.672.580.289.0254.11103.93
Current Portion of Leases
-4.95.346.396.475.07
Current Income Taxes Payable
78.4638.2818.855.5625.99.83
Current Unearned Revenue
69.9134.24110.0273.89102.16110.11
Other Current Liabilities
98.0431.634.9729.7445.5995.96
Total Current Liabilities
1,3271,6791,6651,2451,3601,308
Long-Term Debt
253.45797.81,061929.47836.48
Long-Term Leases
2.783.451.6874.914.94
Long-Term Unearned Revenue
203.47208.94184.14191.3167.04154.66
Long-Term Deferred Tax Liabilities
23.0923.6926.2820.9436.3940.71
Other Long-Term Liabilities
2.62.62.62.62.62.6
Total Liabilities
1,5841,9212,6772,5282,5012,347

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
572.12572.12531.09530.19530.22530.3
Additional Paid-In Capital
1,4051,403495.02477.25476.33480.44
Retained Earnings
3,2483,1092,9042,5762,2022,042
Treasury Stock
-124.81-137.45--0.48-8.68-16.97
Comprehensive Income & Other
-2.530.69134.35137.25136.4133.14
Total Common Equity
5,0984,9484,0643,7203,3363,169
Minority Interest
46.8447.9348.9449.8251.6451.35
Shareholders' Equity
5,1454,9964,1133,7703,3883,220
Total Liabilities & Equity
6,7296,9166,7906,2985,8885,568

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
917.13929.841,6981,5351,6971,452
Net Cash (Debt)
1,9322,1101,299831.28504.82506.11
Net Cash Growth
20.82%62.46%56.24%64.67%-0.26%-18.75%
Net Cash Per Share
3.443.882.451.570.950.96
Filing Date Shares Outstanding
566.48566.88530.03530.19529.64528.63
Total Common Shares Outstanding
566.48566.88531.09530.19529.64528.63
Working Capital
2,6352,6302,4901,9491,8321,628
Book Value Per Share
9.008.737.657.026.305.99
Tangible Book Value
4,8084,6443,7393,3692,9612,770
Tangible Book Value Per Share
8.498.197.046.355.595.24
Buildings
-1,3891,3561,309705.16671.59
Machinery
-446.28425.39328.81190.32181.58
Construction In Progress
-344.23294.56302.75533.08212.04